Research Summary
Analyzed using Evidence Intelligence™

Glutamine supplementation may decrease glycaemia in type 2 diabetes.

Key finding

HbA1c decreased (P = 0.007)

Daily oral supplementation of glutamine with or without sitagliptin in well-controlled type 2 diabetes patients.

Evidence strength

Moderate confidence

Study type

RCTs

Follow-up

Short-Term (≤3 mo)

Some Concerns bias
Last updated July 5, 2026

Quick read

Study at a glance

The essential study design details in one scan.

Population

Young Adult (19–39), Middle Aged (40-64), Male, Female, Asia-Pacific (APAC), with T2 Diabetes

Intervention

Glutamine with Sitagliptin

Study type

RCTs

Follow-up

Short-Term (≤3 mo)

Primary outcome

HbA1c

Comparator

Glutamine + Placebo

Plain-language summary

What this paper says

A plain-language read of the study's main message and where it applies.

Study focus

Daily oral supplementation of glutamine with or without sitagliptin in well-controlled type 2 diabetes patients.

Clinical relevance

This study evaluated Daily oral supplementation of glutamine with or without sitagliptin in well-controlled type 2 diabetes patients.

Keep in mind

Limitations were not clearly described in the extracted text.

Published in

Journal Reference

Publication details and source links for this paper.

Dorit S, Donald JC, Fiona MG, et al. Daily oral supplementation of glutamine with or without sitagliptin decreases glycaemia in type 2 diabetes patients. PLoS ONE. 2014;9(11):e113366. doi:10.1371/journal.pone.0113366

Save this study and add notes to your research library.

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Glutamine with Sitagliptin and Albuminuria, Blood urea nitrogen (BUN), Body weight, and 8 more.

Primary intervention

Glutamine with Sitagliptin

Primary outcomes

  • Albuminuria
  • Blood urea nitrogen (BUN)
  • Body weight

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

11
Evidence pairs
11
Relationships
3
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 68

3

Related topics

11

Evidence pairs

260

Related studies

High relevance in at least one topic

Why it is useful

  • Contributes to 11 evidence relationships
  • Includes primary outcome data
  • Linked to 3 direct semantic evidence topics

Topic contributions

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Core evidence

Study findings

The primary outcomes reported in this study.

StrongDecrease

Albuminuria

Glutamine with Sitagliptin → Albuminuria

Glutamine with Sitagliptin → Albuminuria

Evidence profile

StrongDecreaseClinical Outcomes
Unlock full evidence details
NoneIncrease

Blood urea nitrogen (BUN)

Glutamine with Sitagliptin → Blood urea nitrogen (BUN)

Glutamine with Sitagliptin → Blood urea nitrogen (BUN)

Evidence profile

NoneIncreaseClinical Outcomes
Unlock full evidence details
NoneNo Change

Body weight

Glutamine with Sitagliptin → Body weight

Glutamine with Sitagliptin → Body weight

Evidence profile

NoneNo ChangeWeight & Anthropometrics
Unlock full evidence details
NoneNo Change

Estimated glomerular filtration rate

Glutamine with Sitagliptin → Estimated glomerular filtration rate

Glutamine with Sitagliptin → Estimated glomerular filtration rate

Evidence profile

NoneNo ChangeClinical Outcomes
Unlock full evidence details
StrongDecrease

Fructosamine

Glutamine with Sitagliptin → Fructosamine

Glutamine with Sitagliptin → Fructosamine

Evidence profile

StrongDecreaseClinical Outcomes
Unlock full evidence details
StrongDecrease

HbA1c

Glutamine with Sitagliptin → HbA1c

Glutamine with Sitagliptin → HbA1c

Evidence profile

StrongDecreaseGlycemic Control
Unlock full evidence details
StrongDecrease

Hematocrit

Glutamine with Sitagliptin → Hematocrit

Glutamine with Sitagliptin → Hematocrit

Evidence profile

StrongDecreaseClinical Outcomes
Unlock full evidence details
StrongDecrease

Hemoglobin

Glutamine with Sitagliptin → Hemoglobin

Glutamine with Sitagliptin → Hemoglobin

Evidence profile

StrongDecreaseClinical Outcomes
Unlock full evidence details
NoneNo Change

Plasma Electrolytes

Glutamine with Sitagliptin → Plasma Electrolytes

Glutamine with Sitagliptin → Plasma Electrolytes

Evidence profile

NoneNo ChangeClinical Outcomes
Unlock full evidence details
StrongDecrease

Red Blood Cells

Glutamine with Sitagliptin → Red Blood Cells

Glutamine with Sitagliptin → Red Blood Cells

Evidence profile

StrongDecreaseClinical Outcomes
Unlock full evidence details
NoneNo Change

Serum creatinine

Glutamine with Sitagliptin → Serum creatinine

Glutamine with Sitagliptin → Serum creatinine

Evidence profile

NoneNo ChangeSafety
Unlock full evidence details

Unlock full evidence analysis

Create a free account to access effectiveness ratings, evidence strength and depth scores, consistency analysis, and direct links to all supporting studies.

Unlock Full Analysis

Create a free account to unlock the bias score, detailed effectiveness analysis, and clinical outcomes for this study.

Already have an account?

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on DPP-4 Inhibitors and Kidney Function, DPP-4 Inhibitors and Fructosamine.

Related evidence relationships

Explore in Evidence Archive

This study contributes to the evidence on the following intervention-outcome relationships.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does DPP-4 Inhibitors improve HbA1c?

Emerging Evidence

DPP-4 Inhibitors appears to improve HbA1c.

ConsensusScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    HbA1c

    EvidenceScore™ Emerging | EvidenceScore™ 50.5 | strong positive | ConsensusScore™ Unclear | 1 study

Why this answer: This answer is based on 7 supporting studies with consistent results and a positive effect signal.

Limitations

  • Population details are unavailable.
7 supporting studiesUpdated: Jul 2026

Does DPP-4 Inhibitors affect body weight?

Emerging Evidence

DPP-4 Inhibitors may improve Body Weight.

ConsensusScore™: Results are mixed and should be interpreted cautiously.

Evidence caveat: The available evidence reports mixed findings.

Ranked evidence signals

  1. 1

    Body weight

    EvidenceScore™ Limited | EvidenceScore™ 33.0 | neutral | ConsensusScore™ Unclear | 1 study

Why this answer: This answer is cautious because the available studies report mixed findings.

Limitations

  • Population details are unavailable.
4 supporting studiesUpdated: Jul 2026

Does DPP-4 Inhibitors improve kidney function?

Limited Evidence

Current evidence does not show a clear benefit of DPP-4 Inhibitors for Kidney Function.

ConsensusScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Albuminuria

    EvidenceScore™ Emerging | EvidenceScore™ 50.5 | strong positive | ConsensusScore™ Unclear | 1 study

  2. 2

    Estimated glomerular filtration rate

    EvidenceScore™ Limited | EvidenceScore™ 33.0 | neutral | ConsensusScore™ Unclear | 1 study

  3. 3

    Serum creatinine

    EvidenceScore™ Limited | EvidenceScore™ 33.0 | neutral | ConsensusScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026

Does Glutamine with Sitagliptin improve fructosamine?

Emerging Evidence

Glutamine with Sitagliptin appears to improve Fructosamine.

ConsensusScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Fructosamine

    EvidenceScore™ Emerging | EvidenceScore™ 50.5 | strong positive | ConsensusScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Jul 2026
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, archive views, and research summaries.

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.